Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Agotrig 0.1mg Injection
Manufacturer/Marketed By : BHARAT SERUMS & VACCINES LTD
$4.82 $3.86
Agotrig 0.1mg injection contains an active component as Triptorelin. It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
TRIPTORELIN
Active Pharmaceutical Ingredient
Agotrig 0.1mg Injection
$4.82
$3.86
Agotrig 0.1mg injection contains an active component as Triptorelin. It is a medication that belongs to a class of drugs known as gonadotropin-releasing hormone (GnRH) analogs. It is primarily used in the field of reproductive medicine for the treatment of various conditions related to hormonal imbalance. One of the most common uses is in treating certain hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis. In prostate cancer, for example, this medication is used to lower the levels of testosterone, which can help slow down the growth of cancer cells. It is not recommended to use Agotrig 0.1mg injection in individuals who have a known hypersensitivity or allergic reaction to the medication or any of its components. The safety and effectiveness of this medication have not been established in children, so a healthcare professional will carefully consider and monitor its use in this population. Adults on Agotrig 0.1mg injection may develop osteoporosis, Therefore, if you or anyone in your immediate family has bone thinning, you should inform your doctor. There may be a risk of development of depression in individuals, hence beware of any mood changes during the course of treatment. It is not recommended to use Agotrig 0.1mg injection in pregnant and nursing individuals. Agotrig 0.1mg injection may have cardiovascular effects, including an increased risk of heart attack or stroke. It should be used cautiously in individuals with a history of cardiovascular disease or those at increased risk. It is necessary to inform your doctor if you have diabetes or heart conditions. It is recommended that you must utilize a method of contraception other than the pill while undergoing therapy. Your physician could advise using a barrier form of birth control, like a condom or diaphragm. It is advised to inform your doctor about all the medicines you are taking including herbal, vitamin supplements and over the counter medicines before starting the treatment.
Active Pharmaceutical Ingredient
Uses
• Prostate cancer in men
• Early onset puberty in children 2 years of age and older (precocious puberty)
• Used to treat Endometriosis in females - a condition in which the tissue that normally lines the uterus—grows outside of it.
Benefits
Agotrig 0.1mg injection exerts its therapeutic effect by suppressing the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) through its action on the pituitary gland. This suppression leads to a decrease in the production of sex hormones, such as testosterone and estrogen. By reducing the levels of these hormones, this medication is beneficial in treating hormone-dependent conditions such as prostate cancer, breast cancer, and endometriosis.
Side Effects
Agotrig 0.1mg injection causes some side effects like all medications, although not everyone will experience them.
Most Common Side Effects
• Hot flushes
• Weakness
• Excessive sweating
• Back pain
• Impotence
• Nausea
• Dry mouth
• Pain, bruising, redness at the injection site
• High blood pressure
• Weight gain
• Dizziness
• Headache
• Decreased libido
• Painful periods
Common Side Effects
• Severe allergic reaction (angioedema, anaphylactic reaction)
• Swallowing or breathing trouble
• Increased lymphocytes count in the blood
• Swelling of lips, tongue or throat
How To Use
Agotrig 0.1mg injection is typically administered via injection, either subcutaneously (under the skin) or intramuscularly (into the muscle). The specific dosing and frequency of administration will depend on the individual's condition being treated and their response to the medication. It is important to follow the healthcare professional's instructions regarding the administration technique and schedule.
Safety Advice
• Breast Feeding: The safety of Agotrig 0.1mg injection during breastfeeding is not well established. It is advisable to avoid using it while breastfeeding unless the potential benefits outweigh the potential risks to the nursing infant.
• Alcohol: It is usually not advised to drink alcohol while receiving Agotrig 0.1mg injection therapy. The body's hormone levels, particularly those related to reproductive function, might be impacted by alcohol consumption.
• Liver: Agotrig 0.1mg injection should be used with caution in individuals with liver impairment or liver disease. The metabolism and elimination of this medication may be affected in such cases. It is advised to consult a healthcare provider if you have any concerns on liver health.
• Lungs: Agotrig 0.1mg injection is generally considered safe for use in individuals with lung conditions. However, as with any medication, it is important to consult with a healthcare professional before starting this medication if you have a lung condition or any respiratory issues.
• Driving: Common side effects of Agotrig 0.1mg injection may include hot flashes, mood changes, and fatigue. If any of these side effects occur and significantly impact your alertness, concentration, or motor skills, it is advisable to avoid driving or operating machinery until you feel capable of doing so safely.
• Pregnancy: Agotrig 0.1mg injection is generally not recommended for use during pregnancy. If pregnancy is planned or suspected while using this medication, it is important to inform the healthcare professional promptly. They can provide appropriate guidance and make necessary adjustments to the treatment plan.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.